Atlantic Investment Company’s Gilead Sciences GILD Stock Holding History

Atlantic Investment Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.23M	Buy	12,565 +175	+1%	+$19.4K	3.59%	5
2015 Q2	$1.45M	Buy	12,390 +150	+1%	+$16.4K	3.47%	7
2015 Q1	$1.2M	Hold	12,240	–	–	2.36%	8
2014 Q4	$1.15M	Buy	+12,240	New	+$1.27M	1.62%	7
2014 Q3	–	Sell	-12,985	Closed	-$1.27M	–	6
2014 Q2	$1.08M	Hold	12,985	–	–	0.92%	8
2014 Q1	$920K	Buy	12,985 +125	+1%	+$9.8K	0.89%	12
2013 Q4	$966K	Sell	12,860 -1,050	-8%	-$73.1K	0.85%	11
2013 Q3	$875K	Hold	13,910	–	–	0.57%	14
2013 Q2	$713K	Buy	+13,910	New	+$725K	0.53%	17

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atlantic Investment Company's GILD Position: Q3 2015 in Review

Atlantic Investment Company increased its Gilead Sciences (GILD) stake by 1.4% in Q3 2015, buying an estimated $19.4K and bringing the position to 12,565 shares worth $1.23M. The position accounts for 3.59% of the portfolio, ranked #5.

Atlantic Investment Company first reported a position in GILD in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.45M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Atlantic Investment Company held 12,565 shares of Gilead Sciences worth $1.23M as of Q3 2015.
Atlantic Investment Company bought 175 Gilead Sciences shares in Q3 2015, an estimated $19.4K.
Gilead Sciences made up 3.59% of Atlantic Investment Company's portfolio in Q3 2015, its #5 holding.
Atlantic Investment Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 9 quarters since.
Atlantic Investment Company's Gilead Sciences position peaked at $1.45M in Q2 2015.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Atlantic Investment Company's 13F filing for Q3 2015, filed 13 Nov 2015.